Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;4(5):835-45.
doi: 10.2147/ndt.s2013.

Potential cellular and regenerative approaches for the treatment of Parkinson's disease

Emma L Lane  1 , Olivia J Handley, Anne E Rosser, Stephen B Dunnett
Affiliations

Potential cellular and regenerative approaches for the treatment of Parkinson's disease

Emma L Lane et al. Neuropsychiatr Dis Treat. 2008 Oct.

Abstract

Parkinson's disease is most commonly treated with a range of pharmacotherapeutics, with the more recent introduction of surgical techniques including deep-brain stimulation. These have limited capabilities to improve symptoms of the disease in more advanced stages, thus new therapeutic strategies including the use of viral vectors and stem cells are in development. Providing a continuous supply of dopamine to the striatum in an attempt to improve the treatment of motor symptoms using enzymes in the dopamine synthesis and machinery is one approach. Alternatively, there are tools which may serve to both protect and encourage outgrowth of surviving neurons using growth factors or to directly replace lost innervation by transplantation of primary tissue or stem cell-derived dopaminergic neurons. We summarize some of the potential therapeutic approaches and also consider the recent EU directives on practical aspects of handling viral vectors, cells and tissues, and in the running of clinical trials in Europe which impact on their development.

Keywords: European Union directive; ethics; stem cells; transplantation; viral vector.

PubMed Disclaimer

References

    1. Baker SA, Baker KA, Hagg T. Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur J Neurosci. 2004;20:575–9. - PubMed
    1. Bara-Jimenez W, Bibbiani F, Morris MJ, et al. Effects of serotonin 5-HT1A agonist in advanced Parkinson’s disease. Mov Disord. 2005;20:932–6. - PubMed
    1. Bara-Jimenez W, Dimitrova T, Sherzai A, et al. Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson’s disease. Mov Disord. 2004;19:1183–6. - PubMed
    1. Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells. 2004;22:1246–55. - PubMed
    1. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20:415–55. - PubMed

LinkOut - more resources